Email Updates

You are here

Home»Media

AVAC in the News

  • HIV Testing: A portal for treatment and prevention

    Mitchell Warren calls, on National HIV Testing Day, for individuals to get tested, know their status and take appropriate steps to access treatment and prevention. And also for funders and policymakers to support life-saving and cost-saving testing programs that are the cornerstone of a comprehensive, integrated and sustained response to HIV.

    June 27, 2017
    Treatment
    TheBody.com

  • FDA Approves First Generic Truvada in US

    The US Food and Drug Administration (FDA) has approved the first generic version of emtricitabine/tenofovir disoproxil (Truvada, Gilead Sciences) to both treat and prevent HIV infections in this country, the agency announced today.

    June 9, 2017
    PrEP
    Medscape

  • Trump Administration's Budget Criticized by Medical and Health Advocacy Groups Wary of Cuts

    Medical and health advocacy groups have come out largely in opposition to the Trump administration's proposed cuts in the 2018 budget, with one executive calling it a "disaster" to federal programs and institutions that provide resources to improve health.

    May 24, 2017
    Healthcare Finance

  • Gay in Nigeria: The stark reality for LGBT people in the West African country

    Activist Micheal Ighodaro speaks about being violently attacked in his home city, seeking asylum in the US and the issues that LGBT people across the world.

    May 23, 2017
    General
    Independent

  • Advocacy in Uncertain Times: HIV Vaccine Awareness Day turns 20

    The hard truth is we will pass many more May 18ths before we can celebrate a licensed accessible HIV vaccine. And HIV vaccine research can only succeed with enduring advocacy and fresh voices taking up the charge. That means the next generation of vaccine champions will need to rise to the challenge of keeping the hope for and need for an HIV vaccine in the forefront of HIV advocacy.

    May 18, 2017
    HIV Vaccine
    The Huffington Post

  • Gilead Slowly Rolls out Ads for Truvada for PrEP — 4 Years after Approval

    Gradually ramping up promotion of its HIV-prevention pill, Gilead Sciences has turned to humor, dating apps and social media sites like Tumblr and Snapchat to raise awareness about HIV prevention.

    May 3, 2017
    PrEP
    MM&M

  • HIV, Family Planning Groups Grapple with New WHO Guidance on Popular Contraceptive

    The World Health Organization's reclassification last month of progestogen-only injectable contraceptives has triggered a critical debate in the family planning community over how to manage the potential link between higher rates of HIV acquisition and one of the most popular birth control methods in many at-risk communities.

    April 4, 2017
    Devex

  • HIV Vaccines: where are we now?

    A vaccine for HIV has been sought since the early days of the epidemic. After years of difficulties and setbacks, several new approaches are providing cause for optimism.

    April 1, 2017
    HIV Vaccine
    Lancet

  • Curse or Conundrum? Drawing New Donors When a Big Name is at the Table

    While the Gates Foundation encourages its grantees to diversify, it is often difficult for organizations that get Gates’ funding early on to attract other donors. This is because of a perception that they do not need further support, Peter Matlon, an expert in agricultural development, said in front of the audience at the American Enterprise Institute.

    March 31, 2017
    Devex

  • 40 Organizations Protest in Front of White House on International Women’s Day

    Today, the National LGBTQ Task Force joined 40 national organizations in taking part in a protest in front of the White House against President Donald Trump’s global gag rule.

    March 8, 2017
    LGBT Weekly

Pages